Academic Journal
HDX-MS-Guided computational modeling for rapid and accurate antibody-antigen interface mapping.
| Τίτλος: | HDX-MS-Guided computational modeling for rapid and accurate antibody-antigen interface mapping. |
|---|---|
| Συγγραφείς: | McMahon W; Analytical Sciences, Biopharmaceutical Development, AstraZeneca, Gaithersburg, MD, USA., Zhang H; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Li X; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Oganesyan V; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Payne S; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Mehzabeen N; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Dyk NV; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Liu W; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Howard W; Analytical Sciences, Biopharmaceutical Development, AstraZeneca, Gaithersburg, MD, USA., Zhao P; Analytical Sciences, Biopharmaceutical Development, AstraZeneca, Gaithersburg, MD, USA., Zhang Y; Analytical Sciences, Biopharmaceutical Development, AstraZeneca, Gaithersburg, MD, USA., Fang M; Analytical Sciences, Biopharmaceutical Development, AstraZeneca, Gaithersburg, MD, USA., Chen X; Analytical Sciences, Biopharmaceutical Development, AstraZeneca, Gaithersburg, MD, USA., Mazor Y; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Shi Y; Analytical Sciences, Biopharmaceutical Development, AstraZeneca, Gaithersburg, MD, USA. |
| Πηγή: | MAbs [MAbs] 2026 Dec; Vol. 18 (1), pp. 2722455. Date of Electronic Publication: 2026 Sep 11. |
| Τύπος έκδοσης: | Journal Article |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101479829 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1942-0870 (Electronic) Linking ISSN: 19420862 NLM ISO Abbreviation: MAbs Subsets: MEDLINE |
| Imprint Name(s): | Publication: 2015- : Philadelphia, PA : Taylor & Francis Original Publication: Austin, TX : Landes Bioscience |
| Ιατρικοί όροι (MeSH): | Hydrogen Deuterium Exchange-Mass Spectrometry*/methods , Epitope Mapping*/methods , Epitopes*/chemistry , Epitopes*/immunology , Antigen-Antibody Complex*/chemistry , Antigen-Antibody Complex*/immunology, Immunoglobulin Fab Fragments/chemistry ; Humans ; Models, Molecular ; Crystallography, X-Ray |
| Περίληψη: | Accurate mapping of paratopes and epitopes at antibody-antigen (Ab-Ag) interfaces is essential for the rational design of therapeutic antibodies in early drug development. Traditional methods for determining high-resolution Ab-Ag complex structures, such as X-ray crystallography and cryo-electron microscopy, are labor-intensive and require substantial time and resources. Although recent computational approaches have increased throughput, prediction accuracy and reliability remain limited, particularly without experimental structural constraints. Here, we present a hydrogen-deuterium exchange mass spectrometry (HDX-MS)-guided structural modeling workflow for efficient and accurate epitope and paratope mapping across three prospective case studies in therapeutic protein discovery and engineering. Across these systems, peptide-level HDX-MS data were sufficient to guide docking and structural modeling, whereas targeted electron transfer dissociation (ETD) HDX-MS was applied in one system as a higher-resolution, orthogonal approach to further localize critical binding residues. The workflow was applied to diverse Ab-Ag architectures spanning Fab and VHH binders and homodimeric and heterodimeric antigen ectodomains, and HDX-MS data were integrated with HADDOCK, AlphaFold2, and Protenix to generate Ab-Ag complex models. Comparison with subsequently obtained in-house X-ray crystal structures, used here as orthogonal high-resolution reference structures, showed strong agreement in overall binding orientation and interface placement. These results demonstrate the robustness and practical utility of this integrative approach for structure-informed antibody engineering in therapeutic protein discovery. |
| References: | J Biol Chem. 2014 Dec 19;289(51):35388-96. (PMID: 25344622) Anal Chem. 2007 Nov 15;79(22):8686-93. (PMID: 17935303) Eur J Nucl Med Mol Imaging. 2023 Feb;50(3):679-691. (PMID: 36346438) Bioinformatics. 2023 Jan 1;39(1):. (PMID: 36370083) Nature. 2021 Aug;596(7873):583-589. (PMID: 34265844) Methods Mol Biol. 2018;1785:13-27. (PMID: 29714009) MAbs. 2023 Jan-Dec;15(1):2285285. (PMID: 38010385) Nat Rev Drug Discov. 2018 Jul;17(7):509-527. (PMID: 29904196) J Am Soc Mass Spectrom. 2026 Jun 3;37(6):1391-1401. (PMID: 41915381) Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9029-34. (PMID: 18574150) Anal Chem. 2020 Jun 2;92(11):7453-7461. (PMID: 32427467) Structure. 2020 Jan 7;28(1):119-129.e2. (PMID: 31727476) Science. 2003 Nov 21;302(5649):1364-8. (PMID: 14631033) Biochem J. 2017 May 16;474(11):1867-1877. (PMID: 28381646) Front Anal Sci. 2023;3:. (PMID: 37746528) Cancer Res. 2011 Mar 15;71(6):2250-9. (PMID: 21406401) Front Immunol. 2023 Nov 10;14:1275304. (PMID: 38022650) Transplantation. 1982 Feb;33(2):156-62. (PMID: 6949383) Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4440-5. (PMID: 27036003) Methods Mol Biol. 2018;1785:1-10. (PMID: 29714008) Science. 2018 Aug 31;361(6405):876-880. (PMID: 30166484) Nature. 2024 Jun;630(8016):493-500. (PMID: 38718835) J Struct Biol. 2025 Mar;217(1):108166. (PMID: 39765317) Nat Methods. 2019 Jul;16(7):595-602. (PMID: 31249422) Bioinformatics. 2024 Oct 1;40(10):. (PMID: 39348158) J Am Soc Mass Spectrom. 2022 Feb 2;33(2):215-237. (PMID: 35077179) |
| Contributed Indexing: | Keywords: Antibody-antigen interface mapping; HDX-MS; computational modeling |
| Substance Nomenclature: | 0 (Immunoglobulin Fab Fragments) 0 (Epitopes) 0 (Antigen-Antibody Complex) |
| Entry Date(s): | Date Created: 20260911 Date Completed: 20260911 Latest Revision: 20260917 |
| Update Code: | 20260917 |
| PubMed Central ID: | PMC13577250 |
| DOI: | 10.1080/19420862.2026.2722455 |
| PMID: | 42725674 |
| Βάση Δεδομένων: | MEDLINE |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://resolver.ebsco.com/c/fiv2js/result?sid=EBSCO:cmedm&genre=article&issn=19420870&ISBN=&volume=18&issue=1&date=20261201&spage=2722455&pages=2722455&title=MAbs&atitle=HDX-MS-Guided%20computational%20modeling%20for%20rapid%20and%20accurate%20antibody-antigen%20interface%20mapping.&aulast=McMahon%20W&id=DOI:10.1080/19420862.2026.2722455 Name: Full Text Finder (for New FTF UI) (ns324271) Category: fullText Text: Full Text Finder MouseOverText: Full Text Finder |
|---|---|
| Header | DbId: cmedm DbLabel: MEDLINE An: 42725674 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: HDX-MS-Guided computational modeling for rapid and accurate antibody-antigen interface mapping. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22McMahon+W%22">McMahon W</searchLink>; Analytical Sciences, Biopharmaceutical Development, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+H%22">Zhang H</searchLink>; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Oganesyan+V%22">Oganesyan V</searchLink>; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Payne+S%22">Payne S</searchLink>; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Mehzabeen+N%22">Mehzabeen N</searchLink>; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Dyk+NV%22">Dyk NV</searchLink>; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Liu+W%22">Liu W</searchLink>; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Howard+W%22">Howard W</searchLink>; Analytical Sciences, Biopharmaceutical Development, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Zhao+P%22">Zhao P</searchLink>; Analytical Sciences, Biopharmaceutical Development, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Analytical Sciences, Biopharmaceutical Development, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Fang+M%22">Fang M</searchLink>; Analytical Sciences, Biopharmaceutical Development, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Chen+X%22">Chen X</searchLink>; Analytical Sciences, Biopharmaceutical Development, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Mazor+Y%22">Mazor Y</searchLink>; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Shi+Y%22">Shi Y</searchLink>; Analytical Sciences, Biopharmaceutical Development, AstraZeneca, Gaithersburg, MD, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101479829%22">MAbs</searchLink> [MAbs] 2026 Dec; Vol. 18 (1), pp. 2722455. <i>Date of Electronic Publication: </i>2026 Sep 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: Language Label: Language Group: Lang Data: English – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101479829 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1942-0870 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219420862%22">19420862 </searchLink><i>NLM ISO Abbreviation: </i>MAbs <i>Subsets: </i>MEDLINE – Name: PublisherInfo Label: Imprint Name(s) Group: PubInfo Data: <i>Publication</i>: 2015- : Philadelphia, PA : Taylor & Francis<br /><i>Original Publication</i>: Austin, TX : Landes Bioscience – Name: SubjectMESH Label: MeSH Terms Group: Su Data: <searchLink fieldCode="MM" term="%22Hydrogen+Deuterium+Exchange-Mass+Spectrometry%22">Hydrogen Deuterium Exchange-Mass Spectrometry*</searchLink>/<searchLink fieldCode="MM" term="%22Hydrogen+Deuterium+Exchange-Mass+Spectrometry+methods%22">methods</searchLink> <br /><searchLink fieldCode="MM" term="%22Epitope+Mapping%22">Epitope Mapping*</searchLink>/<searchLink fieldCode="MM" term="%22Epitope+Mapping+methods%22">methods</searchLink> <br /><searchLink fieldCode="MM" term="%22Epitopes%22">Epitopes*</searchLink>/<searchLink fieldCode="MM" term="%22Epitopes+chemistry%22">chemistry</searchLink> <br /><searchLink fieldCode="MM" term="%22Epitopes%22">Epitopes*</searchLink>/<searchLink fieldCode="MM" term="%22Epitopes+immunology%22">immunology</searchLink> <br /><searchLink fieldCode="MM" term="%22Antigen-Antibody+Complex%22">Antigen-Antibody Complex*</searchLink>/<searchLink fieldCode="MM" term="%22Antigen-Antibody+Complex+chemistry%22">chemistry</searchLink> <br /><searchLink fieldCode="MM" term="%22Antigen-Antibody+Complex%22">Antigen-Antibody Complex*</searchLink>/<searchLink fieldCode="MM" term="%22Antigen-Antibody+Complex+immunology%22">immunology</searchLink><br /><searchLink fieldCode="MH" term="%22Immunoglobulin+Fab+Fragments%22">Immunoglobulin Fab Fragments</searchLink>/<searchLink fieldCode="MH" term="%22Immunoglobulin+Fab+Fragments+chemistry%22">chemistry</searchLink> ; <searchLink fieldCode="MH" term="%22Humans%22">Humans</searchLink> ; <searchLink fieldCode="MH" term="%22Models%2C+Molecular%22">Models, Molecular</searchLink> ; <searchLink fieldCode="MH" term="%22Crystallography%2C+X-Ray%22">Crystallography, X-Ray</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Accurate mapping of paratopes and epitopes at antibody-antigen (Ab-Ag) interfaces is essential for the rational design of therapeutic antibodies in early drug development. Traditional methods for determining high-resolution Ab-Ag complex structures, such as X-ray crystallography and cryo-electron microscopy, are labor-intensive and require substantial time and resources. Although recent computational approaches have increased throughput, prediction accuracy and reliability remain limited, particularly without experimental structural constraints. Here, we present a hydrogen-deuterium exchange mass spectrometry (HDX-MS)-guided structural modeling workflow for efficient and accurate epitope and paratope mapping across three prospective case studies in therapeutic protein discovery and engineering. Across these systems, peptide-level HDX-MS data were sufficient to guide docking and structural modeling, whereas targeted electron transfer dissociation (ETD) HDX-MS was applied in one system as a higher-resolution, orthogonal approach to further localize critical binding residues. The workflow was applied to diverse Ab-Ag architectures spanning Fab and VHH binders and homodimeric and heterodimeric antigen ectodomains, and HDX-MS data were integrated with HADDOCK, AlphaFold2, and Protenix to generate Ab-Ag complex models. Comparison with subsequently obtained in-house X-ray crystal structures, used here as orthogonal high-resolution reference structures, showed strong agreement in overall binding orientation and interface placement. These results demonstrate the robustness and practical utility of this integrative approach for structure-informed antibody engineering in therapeutic protein discovery. – Name: Ref Label: References Group: RefInfo Data: J Biol Chem. 2014 Dec 19;289(51):35388-96. (PMID: <searchLink fieldCode="PM" term="%2225344622%22">25344622)</searchLink><br />Anal Chem. 2007 Nov 15;79(22):8686-93. (PMID: <searchLink fieldCode="PM" term="%2217935303%22">17935303)</searchLink><br />Eur J Nucl Med Mol Imaging. 2023 Feb;50(3):679-691. (PMID: <searchLink fieldCode="PM" term="%2236346438%22">36346438)</searchLink><br />Bioinformatics. 2023 Jan 1;39(1):. (PMID: <searchLink fieldCode="PM" term="%2236370083%22">36370083)</searchLink><br />Nature. 2021 Aug;596(7873):583-589. (PMID: <searchLink fieldCode="PM" term="%2234265844%22">34265844)</searchLink><br />Methods Mol Biol. 2018;1785:13-27. (PMID: <searchLink fieldCode="PM" term="%2229714009%22">29714009)</searchLink><br />MAbs. 2023 Jan-Dec;15(1):2285285. (PMID: <searchLink fieldCode="PM" term="%2238010385%22">38010385)</searchLink><br />Nat Rev Drug Discov. 2018 Jul;17(7):509-527. (PMID: <searchLink fieldCode="PM" term="%2229904196%22">29904196)</searchLink><br />J Am Soc Mass Spectrom. 2026 Jun 3;37(6):1391-1401. (PMID: <searchLink fieldCode="PM" term="%2241915381%22">41915381)</searchLink><br />Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9029-34. (PMID: <searchLink fieldCode="PM" term="%2218574150%22">18574150)</searchLink><br />Anal Chem. 2020 Jun 2;92(11):7453-7461. (PMID: <searchLink fieldCode="PM" term="%2232427467%22">32427467)</searchLink><br />Structure. 2020 Jan 7;28(1):119-129.e2. (PMID: <searchLink fieldCode="PM" term="%2231727476%22">31727476)</searchLink><br />Science. 2003 Nov 21;302(5649):1364-8. (PMID: <searchLink fieldCode="PM" term="%2214631033%22">14631033)</searchLink><br />Biochem J. 2017 May 16;474(11):1867-1877. (PMID: <searchLink fieldCode="PM" term="%2228381646%22">28381646)</searchLink><br />Front Anal Sci. 2023;3:. (PMID: <searchLink fieldCode="PM" term="%2237746528%22">37746528)</searchLink><br />Cancer Res. 2011 Mar 15;71(6):2250-9. (PMID: <searchLink fieldCode="PM" term="%2221406401%22">21406401)</searchLink><br />Front Immunol. 2023 Nov 10;14:1275304. (PMID: <searchLink fieldCode="PM" term="%2238022650%22">38022650)</searchLink><br />Transplantation. 1982 Feb;33(2):156-62. (PMID: <searchLink fieldCode="PM" term="%226949383%22">6949383)</searchLink><br />Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4440-5. (PMID: <searchLink fieldCode="PM" term="%2227036003%22">27036003)</searchLink><br />Methods Mol Biol. 2018;1785:1-10. (PMID: <searchLink fieldCode="PM" term="%2229714008%22">29714008)</searchLink><br />Science. 2018 Aug 31;361(6405):876-880. (PMID: <searchLink fieldCode="PM" term="%2230166484%22">30166484)</searchLink><br />Nature. 2024 Jun;630(8016):493-500. (PMID: <searchLink fieldCode="PM" term="%2238718835%22">38718835)</searchLink><br />J Struct Biol. 2025 Mar;217(1):108166. (PMID: <searchLink fieldCode="PM" term="%2239765317%22">39765317)</searchLink><br />Nat Methods. 2019 Jul;16(7):595-602. (PMID: <searchLink fieldCode="PM" term="%2231249422%22">31249422)</searchLink><br />Bioinformatics. 2024 Oct 1;40(10):. (PMID: <searchLink fieldCode="PM" term="%2239348158%22">39348158)</searchLink><br />J Am Soc Mass Spectrom. 2022 Feb 2;33(2):215-237. (PMID: <searchLink fieldCode="PM" term="%2235077179%22">35077179)</searchLink> – Name: SubjectMinor Label: Contributed Indexing Group: Data: <i>Keywords: </i>Antibody-antigen interface mapping; HDX-MS; computational modeling – Name: NumberCAS Label: Substance Nomenclature Group: ID Data: 0 (Immunoglobulin Fab Fragments)<br />0 (Epitopes)<br />0 (Antigen-Antibody Complex) – Name: DateEntry Label: Entry Date(s) Group: Date Data: <i>Date Created: </i>20260911 <i>Date Completed: </i>20260911 <i>Latest Revision: </i>20260917 – Name: DateUpdate Label: Update Code Group: Date Data: 20260917 – Name: PubmedCentralID Label: PubMed Central ID Group: ID Data: PMC13577250 – Name: DOI Label: DOI Group: ID Data: 10.1080/19420862.2026.2722455 – Name: AN Label: PMID Group: ID Data: 42725674 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cmedm&AN=42725674 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/19420862.2026.2722455 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2722455 Subjects: – SubjectFull: Immunoglobulin Fab Fragments chemistry Type: general – SubjectFull: Humans Type: general – SubjectFull: Models, Molecular Type: general – SubjectFull: Crystallography, X-Ray Type: general – SubjectFull: Hydrogen Deuterium Exchange-Mass Spectrometry methods Type: general – SubjectFull: Epitope Mapping methods Type: general – SubjectFull: Epitopes chemistry Type: general – SubjectFull: Epitopes immunology Type: general – SubjectFull: Antigen-Antibody Complex chemistry Type: general – SubjectFull: Antigen-Antibody Complex immunology Type: general Titles: – TitleFull: HDX-MS-Guided computational modeling for rapid and accurate antibody-antigen interface mapping. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: McMahon W – PersonEntity: Name: NameFull: Zhang H – PersonEntity: Name: NameFull: Li X – PersonEntity: Name: NameFull: Oganesyan V – PersonEntity: Name: NameFull: Payne S – PersonEntity: Name: NameFull: Mehzabeen N – PersonEntity: Name: NameFull: Dyk NV – PersonEntity: Name: NameFull: Liu W – PersonEntity: Name: NameFull: Howard W – PersonEntity: Name: NameFull: Zhao P – PersonEntity: Name: NameFull: Zhang Y – PersonEntity: Name: NameFull: Fang M – PersonEntity: Name: NameFull: Chen X – PersonEntity: Name: NameFull: Mazor Y – PersonEntity: Name: NameFull: Shi Y IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2026 Dec Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1942-0870 Numbering: – Type: volume Value: 18 – Type: issue Value: 1 Titles: – TitleFull: MAbs Type: main |
| ResultId | 1 |